Wave Life Sciences (WVE) Payables (2014 - 2026)
Wave Life Sciences' (WVE) quarterly Payables came in at $20.4 million in Q2 2026, up 38.86% YoY from $14.7 million in Q2 2025, and up 6.81% on a QoQ basis from $19.1 million in Q1 2026.
Wave Life Sciences (WVE) Payables (2014 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 13 years of Payables data on file, last reported at $20.4 million in Q2 2026.
- Quarterly Payables rose 38.86% year-over-year to $20.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $20.4 million (up 38.86% YoY) and the FY2025 annual result came in at $15.7 million, down 3.46% from the prior year.
- Payables rose to $20.4 million in Q2 2026, from $19.1 million in the prior quarter.
- In the past five years, Payables ranged from a high of $20.4 million in Q2 2026 to a low of $9.9 million in Q1 2022.
- A 5-year average of $14.5 million and a median of $14.4 million in 2025 frame the typical range for Payables.
- The widest YoY moves for Payables: up 132.32% in 2022, down 26.57% in 2022.
- Tracing WVE's Payables over 5 years: stood at $16.9 million in 2022, then declined by 24.1% to $12.8 million in 2023, then advanced by 26.66% to $16.3 million in 2024, then decreased by 3.46% to $15.7 million in 2025, then gained by 29.69% to $20.4 million in 2026.
- The last three Payables figures came in at $20.4 million (Q2 2026), $19.1 million (Q1 2026), and $15.7 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - | 20.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.36 Mn |
| Mar 31, 2026 | 19.06 Mn |
| Dec 31, 2025 | 15.70 Mn |
| Sep 30, 2025 | 14.49 Mn |
| Jun 30, 2025 | 14.66 Mn |
| Mar 31, 2025 | 14.36 Mn |
| Dec 31, 2024 | 16.26 Mn |
| Sep 30, 2024 | 12.78 Mn |
| Jun 30, 2024 | 18.15 Mn |
| Mar 31, 2024 | 11.73 Mn |
| Dec 31, 2023 | 12.84 Mn |
| Sep 30, 2023 | 12.61 Mn |
| Jun 30, 2023 | 12.38 Mn |
| Mar 31, 2023 | 11.91 Mn |
| Dec 31, 2022 | 16.92 Mn |
| Sep 30, 2022 | 15.93 Mn |
| Jun 30, 2022 | 11.17 Mn |
| Mar 31, 2022 | 9.85 Mn |
| Dec 31, 2021 | 7.28 Mn |
| Sep 30, 2021 | 7.44 Mn |